Press release - November 1, 2019

Richard Carreon, Managing Director & CEO at ImpediMed was interviewed by Health Professional radio discussing Bioimpedance Spectroscopy for Breast Cancer-Related Lymphedema

Richard Carreon, Managing Director & Chief Executive Officer at ImpediMed discusses SOZO®, bioimpedance spectroscopy that enables healthcare professionals to non-invasively measure, monitor and better manage lymphedema, particularly in breast cancer surgery patients at a much earlier point.  

Listen to interview